Skip to content
INPLASY
INPLASY

International Platform of Registered Systematic Review and Meta-analysis Protocols

  • Home
  • About us
    • Our History
    • Fees & Services
    • INPLASY registration
    • Platform features
    • INPLASY – reference
    • Our team
    • Become a member
  • Register
  • Log In
  • Browse
  • Submit Now
    • Systematic review
    • Scoping review
    • Methodological studies
    • Update a protocol
    • Update review status
    • Submit with edited file
    • Membership area
  • Resources
    • How to submit
    • How to cite INPLASY
    • Step by step (video)
    • Articles registered on INPLASY.com
    • References
  • Contact Us

INPLASY2022110062

Efficacy and safety of Aldafermin（NGM282） in reducing liver fibrosis in patients with NASH: a systematic evaluation and meta-analysis

Keywords: Aldafermin; Non-alcoholic Fatty Liver Disease; Systematic evaluation; Meta-analysis.

Download PDF - 2022110062

Download 1st Version - This version was published on 13 November 2022 and is not the current version.

Review Status: Completed but not published

Copyright © 2020-2025 INPLASYⓇ
Published by INPLASYⓇ